Last Updated: 11/09/2022

MACEPA IV: Advancing subnational tailoring and impact in priority geographies

Objectives

The main objective of this grant is to advance data-driven, subnationally tailored malaria interventions in high burden Africa, along with targeted support to and time-limited transition from previously prioritized elimination geographies.

Primary outcome:

Accelerated reductions in burden and transmission of malaria in prioritized geographies.

Secondary investment outcomes:

  1. Data systems and data use: Increased availability and use of high-quality data to determine context-appropriate malaria interventions.
  2. Policies and guidelines: Adoption of national strategies and policies enabling subnational targeting of context-appropriate malaria interventions.
  3. Intervention coverage and targeting: Increased effective coverage of context-appropriate malaria interventions.
  4. Resource allocation and alignment: Increased allocation of resources for context-appropriate malaria interventions.
Rationale and Abstract

In 2020, the Bill & Melinda Gates Foundation awarded the PATH Malaria Control and Elimination Partnership in Africa (MACEPA) the four-year MACEPA IV: Advancing subnational tailoring and impact in priority geographies grant. This latest investment sees MACEPA continuing a collaboration with African countries that began in 2005 to scale interventions to reduce malaria burden, generate evidence, and support planning for new strategies to accelerate toward elimination. Specifically, this newest iteration of MACEPA builds on previous investments in Ethiopia, Senegal-The Gambia, and Zambia, and identifies opportunities in new, high-burden geographies (e.g., the Democratic Republic of the Congo and Nigeria).

Date

Sep 2020 — Aug 2024

Total Project Funding

$36.31M

Funding Details
SHARE

Related Resources

Related Projects

SHARE